Julia Lee
Allergy & Immunology · Los Angeles, CANPI 1700225422
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,979 of the $3,362 with a category attached, or 88.6%. It is spread thinly across 18 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,243, more than ten times the $138 reported in 2019.
Across 103 payments — averaging $32.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$663
- Stryker$509
- Galderma Laboratories, L.p.$410
- Regeneron Healthcare Solutions, Inc.$338
- Novartis$320
- Pfizer$293
- plus $828 from 12 others
What the payments were for
- Travel & lodging$3109%
- Food & beverage$2,97989%
- Education$742%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 22 | $663 |
| Stryker | 3 | $509 |
| Galderma Laboratories, L.p. | 7 | $410 |
| Regeneron Healthcare Solutions, Inc. | 10 | $338 |
| Novartis | 12 | $320 |
| Pfizer | 12 | $293 |
| AstraZeneca | 10 | $212 |
| Sanofi | 9 | $199 |
| Genentech USA, Inc. | 3 | $87 |
| AbbVie | 4 | $60 |
| CSL Behring | 2 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Alk-abello, Inc | 2 | $45 |
| Amgen | 1 | $29 |
| Incyte Corporation | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| QOL Medical, LLC | 1 | $21 |
| Optinose US, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$310
- NEMLUVIO$196
- CORE$150
- NUCALA$121
- EUCRISA$110
How this compares
$3,362 in reported general payments places this provider in the 55th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $51,764 |
| Ipratropium Bromide | 16 | $1,021 |
| Montelukast Sodium | 27 | $245 |
| Famotidine | 16 | $130 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Los Angeles
- Yat Choi KwongLos Angeles$181K
- Asif RafiLos Angeles$49K
- Sheila Bonilla-TandocLos Angeles$25K
- Raffi TachdjianSanta Monica$3.7M
- Bob GengSan Diego$3.3M
- Vinay MehtaLaguna Niguel$1.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Brian Modenala Jolla$453K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.